You have 9 free searches left this month | for more free features.

acalabrutinib

Showing 76 - 86 of 86

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Acalabrutinib
  • Chandler, Arizona
  • +107 more
Mar 8, 2022

Multiple Myeloma (MM) Trial in Baltimore, Leicester, London (acalabrutinib)

Completed
  • Multiple Myeloma (MM)
  • acalabrutinib
  • Baltimore, Maryland
  • +2 more
Jul 15, 2020

Lymphoma, Mantle Cell Trial in Worldwide (Acalabrutinib, Bendamustine, Rituximab)

Recruiting
  • Lymphoma, Mantle Cell
  • Acalabrutinib
  • +3 more
  • Downey, California
  • +231 more
Jan 16, 2023

Covid19 Trial in Philippines (Remdesivir, Hydroxychloroquine, Lopinavir / Ritonavir)

Completed
  • Covid19
  • Baguio City, Benguet, Philippines
  • +24 more
Feb 27, 2022

Advanced Haematological Malignancies Trial in Worldwide (AZD4573, Acalabrutinib)

Recruiting
  • Advanced Haematological Malignancies
  • Duarte, California
  • +38 more
Jul 22, 2022

Non-hodgkin Lymphoma,B Cell Trial in Seoul (Acalabrutinib)

Unknown status
  • Non-hodgkin Lymphoma,B Cell
  • Acalabrutinib
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Sep 17, 2019

NSCLC Trial in Goodyear (Pembrolizumab, Acalabrutinib)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Goodyear, Arizona
    Western Regional Medical Center/Cancer Treatment Center of Ameri
Aug 22, 2019

Lymphoma, Mantle-Cell Trial in Worldwide (Pirtobrutinib, Ibrutinib, Acalabrutinib)

Recruiting
  • Lymphoma, Mantle-Cell
  • Phoenix, Arizona
  • +158 more
Aug 15, 2022

Richter Syndrome Trial (Acalabrutinib, Cyclophosphamide, Doxorubicin)

Not yet recruiting
  • Richter Syndrome
  • Acalabrutinib
  • +5 more
  • (no location specified)
Mar 31, 2019

Rheumatoid Arthritis Trial in United States (acalabrutinib, Placebo)

Completed
  • Rheumatoid Arthritis
  • acalabrutinib
  • Placebo
  • Anniston, Alabama
  • +16 more
Mar 25, 2019

Mantle Cell Lymphoma Trial (acalabrutinib, ibrutinib, rituximab)

Withdrawn
  • Mantle Cell Lymphoma
  • acalabrutinib
  • +2 more
  • (no location specified)
May 12, 2016